PolyPid Ltd
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About PolyPid Ltd
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
/ 
Frequently asked questions
To buy PolyPid Ltd stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for PolyPid Ltd by name or ticker, choose the number of shares, and place your order.
The ticker symbol for PolyPid Ltd is PYPD:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
PolyPid Ltd has its primary listing on NASDAQ. You can trade PolyPid Ltd with a Saxo account, alongside thousands of other stocks worldwide.
Yes, PolyPid Ltd is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include PolyPid Ltd as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like PolyPid Ltd.